Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Daniel Lelièvre

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|March 13, 2019
Preexposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment InterruptionJean-Daniel Lelièvre
Revue Francophone Des Laboratoires : RFL|June 11, 2020
[Vaccine of the future]Jean-Daniel Lelièvre
The Journal of Infectious Diseases|February 20, 2019
Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine CandidateJean-Daniel Lelièvre, Laurent Hocqueloux
Current Opinion in HIV and AIDS|April 18, 2009
Perspectives on interleukin-7 therapy in HIV infectionJean Daniel Lelièvre, Yves Lévy
La Revue Du Praticien|December 17, 2014
[Lines of research in the treatment of HIV infection]Maryline Saidani, Jean-Daniel Lelièvre
Journal of Virus Eradication|August 3, 2016
HIV-1 prophylactic vaccines: state of the artJean-Daniel Lelièvre, Yves Lévy
BMJ Case Reports|November 23, 2016
Successful improvement of Buschke-Löwenstein tumour in an HIV-infected patient with antiretroviral therapy aloneCamille Grodner, Aurélia Henn, Jean-Daniel Lelièvre, et al.
Biochemical and Biophysical Research Communications|May 6, 2003
Mitochondria in HIV-1-induced apoptosisDamien Arnoult, Frédéric Petit, Jean-Daniel Lelièvre, et al.
Mitochondrion|August 27, 2005
HIV-1 triggers mitochondrion deathDamien Arnoult, Laurence Viollet, Frédéric Petit, et al.
Expert Review of Vaccines|September 8, 2017
Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccinesMathieu Surenaud, Christine Lacabaratz, Gérard Zurawski, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|March 13, 2019
Preexposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment InterruptionJean-Daniel Lelièvre
Revue Francophone Des Laboratoires : RFL|June 11, 2020
[Vaccine of the future]Jean-Daniel Lelièvre
The Journal of Infectious Diseases|February 20, 2019
Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine CandidateJean-Daniel Lelièvre, Laurent Hocqueloux
Current Opinion in HIV and AIDS|April 18, 2009
Perspectives on interleukin-7 therapy in HIV infectionJean Daniel Lelièvre, Yves Lévy
La Revue Du Praticien|December 17, 2014
[Lines of research in the treatment of HIV infection]Maryline Saidani, Jean-Daniel Lelièvre
Journal of Virus Eradication|August 3, 2016
HIV-1 prophylactic vaccines: state of the artJean-Daniel Lelièvre, Yves Lévy
BMJ Case Reports|November 23, 2016
Successful improvement of Buschke-Löwenstein tumour in an HIV-infected patient with antiretroviral therapy aloneCamille Grodner, Aurélia Henn, Jean-Daniel Lelièvre, et al.
Biochemical and Biophysical Research Communications|May 6, 2003
Mitochondria in HIV-1-induced apoptosisDamien Arnoult, Frédéric Petit, Jean-Daniel Lelièvre, et al.
Mitochondrion|August 27, 2005
HIV-1 triggers mitochondrion deathDamien Arnoult, Laurence Viollet, Frédéric Petit, et al.
Expert Review of Vaccines|September 8, 2017
Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccinesMathieu Surenaud, Christine Lacabaratz, Gérard Zurawski, et al.
Pageof 8